Results - Announcements
Camlin Fine Sciences Ltd share price advanced by 5.40% to Rs 88.59. The Company's net profit contracted by 11.66% to Rs 29.7 crore, while revenue from operations eased by 5.46% to Rs 491.47 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.64 lakh crore, rising by 13.18%. It has marginally improved by 0.04% over last one week and eased lower by 7.04% in last one month while the market capitalization of Camlin Fine Sciences Ltd has inched up 5.64% and 31.67% in the same period respectively.
Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 36.51 crore in Q3 FY26, expanding by 302.98% year-on-year, and rising 7.10% quarter-on-quarter. EBITDA came in at Rs 3 crore, tumbling by 108.70% YoY and plunging by 134.38% sequentially.
Total expenses slightly declined by 3.89% to Rs 509.15 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 264.2 crore, contracting by 15.42% YoY, while employee benefits expense was at Rs 72.27 crore, registering a marginal contraction of 1.58% YoY.
For the TTM ended FY26, revenue from operations inched higher 5.81% to Rs 1723.31 crore, while net profit tumbled by 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA surged by 20985% to Rs 78.09 crore, and PBT plunged by 149.54% to Rs 31.99 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25.
Camlin Fine Sciences Ltd nosedived by 55.65% in last one year, underperforming the benchmark BSE Sensex which has softened by 9.87% during the same period.